Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 360.49M P/E - EPS this Y 88.20% Ern Qtrly Grth -
Income -16.54M Forward P/E -64.62 EPS next Y 950.00% 50D Avg Chg -5.00%
Sales 173.48M PEG - EPS past 5Y -53.59% 200D Avg Chg -13.00%
Dividend N/A Price/Book 3.69 EPS next 5Y - 52W High Chg -39.00%
Recommedations 1.70 Quick Ratio 1.98 Shares Outstanding 43.83M 52W Low Chg 17.00%
Insider Own 5.57% ROA -4.01% Shares Float 35.67M Beta 1.13
Inst Own 75.94% ROE -17.15% Shares Shorted/Prior 1.63M/1.80M Price 8.40
Gross Margin 79.37% Profit Margin -9.53% Avg. Volume 182,104 Target Price 15.86
Oper. Margin -0.89% Earnings Date Nov 5 Volume 174,523 Change -1.29%
About AxoGen, Inc.

Axogen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. Axogen, Inc. is headquartered in Alachua, Florida.

AxoGen, Inc. News
11/09/24 Axogen Third Quarter 2024 Earnings: Beats Expectations
11/08/24 AxoGen Reports Strong Q3 2024 Revenue Growth
11/08/24 Axogen Inc (AXGN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements
11/07/24 AxoGen: Q3 Earnings Snapshot
11/07/24 Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA Update
10/24/24 Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024
10/14/24 AxoGen (AXGN) Surges 8.2%: Is This an Indication of Further Gains?
10/09/24 Axogen Inc (AXGN) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ...
10/08/24 Axogen, Inc. (NASDAQ:AXGN) is a favorite amongst institutional investors who own 63%
09/24/24 Zacks.com featured highlights include Bioventus, Great Lakes Dredge & Dock and AxoGen
09/23/24 First September Gains in 5 Years? Buy 3 Breakout Stocks Now
09/20/24 Is Aveanna Healthcare (AVAH) Outperforming Other Medical Stocks This Year?
09/19/24 Abbott Stock Hurt by Macroeconomic Issues & FX Headwind
09/11/24 AxoGen, Inc. (NASDAQ:AXGN): Are Analysts Optimistic?
09/06/24 Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®
09/04/24 AxoGen, Inc. (AXGN) Hit a 52 Week High, Can the Run Continue?
09/03/24 Axogen Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(C)(4)
08/30/24 What Makes AxoGen (AXGN) a Strong Momentum Stock: Buy Now?
08/23/24 Wall Street Analysts See a 25.51% Upside in AxoGen (AXGN): Can the Stock Really Move This High?
08/19/24 AxoGen, Inc. (AXGN) Hits Fresh High: Is There Still Room to Run?
AXGN Chatroom

User Image JSmeds21 Posted - 1 week ago

$AXGN anyone else see head and shoulders pattern forming?

User Image YourThoughts Posted - 1 week ago

$AXGN reset after earnings, now on to new ATH

User Image dustin1101 Posted - 1 week ago

$AXGN loading the boat while these fools sell.

User Image jlsnet22 Posted - 1 week ago

$AXGN I just listened to the recorded earnings call from this morning on the company’s website. It was a very positive call. Company says their guidance is by intention conservative. They said fourth-quarter may be impacted by some supply chain issues caused by the hurricane. The key take away from the call is their products are still so new to the market and have such positive outcomes that there is significant potential for growth.

User Image YourThoughts Posted - 1 week ago

$INTC has a -1800 surprise earnings and drops over 22%. $AXGN has a +1060 surprise earnings and drops over 22% 🤣

User Image kubota2323 Posted - 1 week ago

$AXGN Raymond James raised the firm’s price target on AxoGen (AXGN) to $18, while keeping an Outperform rating on the shares. The firm appreciates that expectations were high heading into Q3, but saw nothing in the Q3 results and views the selloff in the shares as “excessive.” Raymond James further sees Q3 as evidence that this business can sustainably grow revenue in the teens with an improving, and attractive, profit profile. The firm also believes the new CEO Mike Dale is the right person to drive this progress.

User Image YourThoughts Posted - 1 week ago

$AXGN

User Image dustin1101 Posted - 1 week ago

$AXGN Got some 12.10s thanks.

User Image kubota2323 Posted - 2 weeks ago

$AXGN added.

User Image HaltTradeAlert Posted - 2 weeks ago

$AXGN Halt Time: 09:33:32 Issue Symbol: AXGN Reason Code: LUDP Last Price: $11.91 Volume: 68.8 K Members get this halt alert with no delay and with more info: shares outstanding, market cap, relative volume, and percentage change on the day. Also, halt alerts for pre-market hours and after market hours which is extremely important for Code T1 News Pending Alerts!! And free real time news catalyst alerts!

User Image YourThoughts Posted - 2 weeks ago

$AXGN frozen

User Image YourThoughts Posted - 2 weeks ago

$AXGN 50

User Image jlsnet22 Posted - 2 weeks ago

$AXGN Great results this morning. This is a very much undiscovered stock.

User Image YourThoughts Posted - 2 weeks ago

$AXGN

User Image LuckEtradER Posted - 1 month ago

$AXGN of all the stocks I’m into at the moment this is one I really wish selfishly would drop back below $10 lol… love this one. Surprised it’s staying here when fda approval won’t happen for 6 months. Would love to load up and get some cheapies lol. Really bright future here for this company. I know someone who works for them and didn’t expect this move to happen pre approval

User Image WeeklyTrader Posted - 1 month ago

Bearish signals are flashing! $AXGN 12.5p RSI: 57.65% 50-day MA: $12.84 200-day MA: $9.19

User Image LuckEtradER Posted - 1 month ago

$AXGN one of my favs… fda approval can’t get here quickly enough. Mark your calendars! 2025 she really breaks out IMO

User Image StockConsultant Posted - 1 month ago

$AXGN Axogen stock, strong day watch for breakout

User Image jlsnet22 Posted - 1 month ago

$AXGN

User Image LuckEtradER Posted - 2 months ago

$AXGN she’s gonna be a monster eventually… gotta be patient with recent fda submission. Bummed this won jumped this quickly from $5’s… was waiting on some spare funds to get in and unfortunately it moved too fast. Will be adding here early next year as we approach fda decision (which is a no brainer IMHO). I know someone who works for them and he’s beyond excited about the future here.

User Image IN0V8 Posted - 2 months ago

$AXGN Raymond James raises target price to $15 from $13

User Image briefingcom Posted - 2 months ago

$AXGN: AxoGen has completed the rolling submission process for its Biologics License Application to the U.S. FDA for Avance Nerve Graft https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20240906070347AXGN&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

User Image Stock_Titan Posted - 2 months ago

$AXGN Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft® https://www.stocktitan.net/news/AXGN/axogen-completes-submission-of-biologics-license-application-to-u-s-bi9ub47f6omd.html

User Image YourThoughts Posted - 08/30/24

$AXGN nice week

User Image Doozio Posted - 3 months ago

$AXGN 8/8 gap n go in 🧠⏰♾️. Until it’s not. Bahhhh it is.

User Image StockInvest_us Posted - 3 months ago

Signal alert: $AXGN - Overbought Trend Short (Overvalued) https://stockinvest.us/l/26Y3SlJfeJ

User Image StockBoyAri Posted - 3 months ago

$AXGN I like this one. I think this keeps climbing. I will add as I go but I see $12-$13 very soon. Just my opinion of course.

User Image Fullratio Posted - 3 months ago

$AXGN total assets is 100% higher than its total liabilities: https://fullratio.com/stocks/nasdaq-axgn/axogen

User Image MakingDreamsReality Posted - 3 months ago

PM mOOvers 👀 $ROAD - Construction Partners Q3 2024 GAAP EPS $0.59 Beats $0.54 Estimate, Sales $517.794M Beat $503.567M Estimate $AXGN - Axogen Q2 2024 Adj. EPS $0.05 Beats $(0.04) Estimate, Sales $47.912M Beat $43.391M Estimate $AKAM -Akamai Techs Q2 2024 Adj. EPS $1.58 Beats $1.53 Estimate, Sales $979.580M Beat $977.242M Estimate $SG - Sweetgreen Q2 2024 GAAP EPS $(0.13) Misses $(0.12) Estimate, Sales $184.641M Beat $180.782M Estimate $INOD - Innodata Q2 Sales $32.553M Beat $27.593M Estimate

User Image hiloSF Posted - 3 months ago

"8 Trading Tips for Gap Up Stocks: Understanding Stock Chart Technical Analysis and Trading Strategies" 🐸🐾 👉 https://dreamchaserx.com/8-trading-tips-for-gap-up-stocks $STUDY $LUMN $AXGN $ASPN $GVP

Analyst Ratings
JMP Securities Market Outperform Aug 9, 24
Raymond James Outperform Jul 1, 24
Canaccord Genuity Buy Jun 20, 24
Cantor Fitzgerald Overweight Jan 19, 24
Canaccord Genuity Buy Dec 7, 23
Leerink Partners Outperform Oct 16, 23
Cantor Fitzgerald Overweight Sep 26, 23
Cantor Fitzgerald Overweight Aug 22, 23
JMP Securities Market Outperform May 10, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Freitag Gregory Gene Director Director Jun 01 Sell 8.7 41,980 365,226 290,135 06/05/23
Freitag Gregory Gene Director Director Jun 01 Option 0 6,459 296,594 06/05/23
MARIANI PETER J EVP & Chief Financia.. EVP & Chief Financial Officer Jan 30 Sell 9.53 42,981 409,609 61,945 02/01/23
MARIANI PETER J EVP & Chief Financia.. EVP & Chief Financial Officer Jan 30 Option 5.04 62,818 316,603 76,495 02/01/23
DeVinney Erick Wayne VP Peripheral Nerve.. VP Peripheral Nerve Science Dec 27 Option 5.09 20,000 101,800 116,752 12/28/22
Freitag Gregory Gene Director Director Nov 08 Sell 12.50 13,000 162,500 352,583 11/10/22
Freitag Gregory Gene Director Director Aug 10 Sell 9.696 8,886 86,159 365,583 08/11/22
Freitag Gregory Gene Director Director Aug 04 Sell 10.51 37,046 389,353 374,469 08/08/22
Freitag Gregory Gene Director Director Jul 25 Option 3.38 83,000 280,540 441,811 07/26/22
Donovan Michael Patrick VP Operations VP Operations Feb 22 Option 5.27 15,000 79,050 57,453 02/24/22
Donovan Michael Patrick VP Operations VP Operations Feb 09 Option 5.14 20,000 102,800 46,029 02/09/21
DeVinney Erick Wayne VP, Clinical&Transla.. VP, Clinical&Translational Sc Dec 30 Sell 17.81 371 6,608 63,240 12/30/20
Donovan Michael Patrick VP Operations VP Operations Dec 30 Sell 17.81 567 10,098 27,762 12/30/20
Zaderej Karen L. CEO CEO Dec 22 Sell 16.42 1,275 20,936 646,719 12/22/20
Friedman Mark Louis VP,Regulatory & Qual.. VP,Regulatory & Quality Dec 22 Sell 16.42 96 1,576 8,893 12/22/20